[go: up one dir, main page]

TWI339582B - Use of alkylphosphocholines in the preventive application of protozoal diseases - Google Patents

Use of alkylphosphocholines in the preventive application of protozoal diseases

Info

Publication number
TWI339582B
TWI339582B TW092100614A TW92100614A TWI339582B TW I339582 B TWI339582 B TW I339582B TW 092100614 A TW092100614 A TW 092100614A TW 92100614 A TW92100614 A TW 92100614A TW I339582 B TWI339582 B TW I339582B
Authority
TW
Taiwan
Prior art keywords
alkylphosphocholines
protozoal diseases
preventive application
preventive
application
Prior art date
Application number
TW092100614A
Other languages
English (en)
Chinese (zh)
Other versions
TW200302103A (en
Inventor
Jurgen Engel
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of TW200302103A publication Critical patent/TW200302103A/zh
Application granted granted Critical
Publication of TWI339582B publication Critical patent/TWI339582B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW092100614A 2002-01-25 2003-01-13 Use of alkylphosphocholines in the preventive application of protozoal diseases TWI339582B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (de) 2002-01-25 2002-01-25 Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen

Publications (2)

Publication Number Publication Date
TW200302103A TW200302103A (en) 2003-08-01
TWI339582B true TWI339582B (en) 2011-04-01

Family

ID=7713213

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092100614A TWI339582B (en) 2002-01-25 2003-01-13 Use of alkylphosphocholines in the preventive application of protozoal diseases

Country Status (16)

Country Link
EP (1) EP1467742A1 (de)
JP (1) JP2005515244A (de)
CN (1) CN1622811A (de)
AR (1) AR038224A1 (de)
AU (1) AU2003236787B2 (de)
BR (1) BR0307021A (de)
CA (1) CA2470185A1 (de)
CO (1) CO5601024A2 (de)
DE (1) DE10203195A1 (de)
IL (2) IL162492A0 (de)
MX (1) MXPA04007193A (de)
NZ (1) NZ548040A (de)
PE (1) PE20030732A1 (de)
TW (1) TWI339582B (de)
WO (1) WO2003061669A1 (de)
ZA (1) ZA200404690B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (de) * 2005-02-23 2007-10-15 Obwaller Andreas Dr Reinigungsmittel für kontaktlinsen
EP1800684A1 (de) * 2005-12-20 2007-06-27 Zentaris GmbH Neue Alkylphospholipidderivate und deren Verwendung
AU2006328479B2 (en) * 2005-12-19 2012-03-08 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US5985935A (en) * 1992-03-06 1999-11-16 Statens Seruminstitut Treatment and prophylaxis of diseases caused by parasites, or bacteria
EP1051159B1 (de) * 1998-01-22 2002-04-10 Zentaris AG Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
DE10020812C2 (de) * 2000-04-20 2003-06-26 Robert Koch Inst Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika
WO2002036588A2 (en) * 2000-11-06 2002-05-10 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
EP1467742A1 (de) 2004-10-20
IL162492A (en) 2009-12-24
TW200302103A (en) 2003-08-01
ZA200404690B (en) 2004-09-27
CA2470185A1 (en) 2003-07-31
WO2003061669A1 (de) 2003-07-31
JP2005515244A (ja) 2005-05-26
IL162492A0 (en) 2005-11-20
AU2003236787B2 (en) 2007-03-22
PE20030732A1 (es) 2003-09-27
CO5601024A2 (es) 2006-01-31
BR0307021A (pt) 2004-11-03
MXPA04007193A (es) 2004-10-29
AR038224A1 (es) 2005-01-05
CN1622811A (zh) 2005-06-01
DE10203195A1 (de) 2003-08-07
NZ548040A (en) 2007-06-29

Similar Documents

Publication Publication Date Title
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
SI1583542T1 (sl) Sestavki in postopki za kombinacijsko antivirusnoterapijo
EP1572890A4 (de) Slc7s als modifikatoren des p53-wegs und verwendungsverfahren
IL163725A0 (en) Administration of agents for the treatment of inflammation
EP1575480A4 (de) Zusammensetzungen und verfahren zur behandlung von immunbedingten erkrankungen
EP1578367A4 (de) Zusammensetzungen und verfahren zur behandlung von immunerkrankungen
EP1572116A4 (de) Zusammensetzungen und verfahren für die behandlung von immunkrankheiten
EP1576137A4 (de) Zusammensetzungen und verfahren für die behandlung von immunkrankheiten
EP1567157A4 (de) Verfahren zur verwendung und zusammensetzungen, umfassend immunomodulatorische verbindungen für die therapie und behandlung von knochenmarkbildungskrankheiten
PL374118A1 (en) Interleukin-1 receptors in the treatment of diseases
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
AU2003284275A8 (en) Effervescent compositions comprising bisphosphonates and methods related thereto
AU2003215257A8 (en) Modified defensins and their use
GB0213869D0 (en) The treatment of pain
GB0207411D0 (en) Azole compounds and their therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
LT1496918T (lt) Natrio meta-arsenito naudojimas navikams gydyti
TWI339582B (en) Use of alkylphosphocholines in the preventive application of protozoal diseases
AU2003205963A8 (en) Azaphenylalanine derivatives and their use as antithrombotic agents
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
IL164951A0 (en) The treatment of pain with lfendropil
GB0201025D0 (en) The treatment of degenerative diseases
EP1488800A4 (de) Mittel zur behandlung von protozoenerkrankungen
AU2003236787A1 (en) Use of alkylphosphocholines for the preventative treatment of protozoan diseases

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent